Internal Medicine, Rheumatology · Bullhead City, AZ
NPI
1871553982
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3003 Hiway 95, Ste 100
Bullhead City, AZ, 86442
Phone (928) 704-5400
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
98,460 services
Medicare patients, 2024
928
Average age 74
Drug cost, 2024
$2.1M
5,180 prescriptions
Company payments, 2025
$129
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Burhan F Chinikhanwala was code J0129 (injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 14,300 times for 21 patients. In total Burhan F Chinikhanwala billed 98,460 services in 30 codes, and Medicare paid $1.5M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-07-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 14,300 | 21 | $33.77 | $483K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 12,336 | 18 | $9.08 | $112K |
| J0897 Injection, denosumab, 1 mg | Office | 10,920 | 107 | $20.18 | $220K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 7,430 | 24 | $25.00 | $186K |
| 99213 Office E&M - Established | Office | 1,854 | 786 | $61.45 | $114K |
| 20610 Joint Injection | Office | 468 | 132 | $70.47 | $33K |
| J7321 Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 462 | 47 | $56.49 | $26K |
| 96365 Intravenous Infusion, Hydration | Office | 317 | 44 | $47.65 | $15K |
| 96372 Injection Administration | Office | 246 | 115 | $11.13 | $2,737 |
| 99204 Office E&M - New | Office | 240 | 240 | $112.33 | $27K |
| 99212 Office E&M - Established | Office | 207 | 129 | $37.66 | $7,796 |
| 96415 Chemotherapy Administration | Office | 175 | 28 | $21.41 | $3,747 |
| 96413 Chemotherapy Administration | Office | 158 | 28 | $99.87 | $16K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 152 | 24 | $0.52 | $78.53 |
| 99214 Office E&M - Established | Office | 100 | 89 | $89.77 | $8,977 |
By year: 2022 $1.6M for 96,998 services; 2023 $1.4M for 82,522 services; 2024 $1.5M for 98,460 services.
Medicare prescription drug claims, 2024
In 2024, the drug Burhan F Chinikhanwala prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,760 prescriptions and refills. In total Burhan F Chinikhanwala wrote 5,180 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,760 | 2,996 | 393 | $67K |
| Methotrexate Methotrexate Sodium | 908 | 1,754 | 212 | $19K |
| Prednisone Generic | 557 | 753 | 160 | $2,759 |
| Leflunomide Generic | 302 | 618 | 79 | $16K |
| Alendronate Sodium Generic | 180 | 404 | 61 | $1,252 |
| Meloxicam Generic | 174 | 222 | 35 | $624 |
| Gabapentin Generic | 155 | 249 | 42 | $1,781 |
| Sulfasalazine Generic | 142 | 290 | 41 | $5,294 |
| Duloxetine Hcl Generic | 121 | 183 | 26 | $1,680 |
| Folic Acid Generic | 101 | 263 | 28 | $905 |
| Enbrel Sureclick Etanercept | 62 | 62 | Under 11 | $462K |
| Humira(Cf) Pen Adalimumab | 45 | 50 | Under 11 | $341K |
| Etodolac Generic | 42 | 56 | 12 | $1,900 |
| Minocycline Hcl Generic | 36 | 48 | Under 11 | $737 |
| Methylprednisolone Generic | 31 | 33 | Under 11 | $304 |
Brand drugs: 466 claims; generic drugs: 4,714 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Burhan F Chinikhanwala $129 ($129 in general payments such as food, travel and fees) from 1 company. The largest payer was UCB, Inc. with $129.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 1 | $129 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.